Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer-driving protein long considered impossible to target with drugs – a discovery that could open the door to a new class of treatments for leukemia and other hard-to-treat cancers.